The high cost of cardiac implantable electronic devices (CIEDs) is the most significant barrier to the lack of treatment in low- and middle-income countries (LMICs). The literature suggests that reusing CIEDs is safe and could therefore be a cost-effective alternative for patients who do not have access to new devices